Related Insights

Non-dilutive capital for biotech startups, Part 3

 
Anton Xavier MSc, MBA

The new baseload: How flexibility and diversification will power the energy transition

 
Jordan Kanis

How to raise startup funds in a tough market — according to a life science investor

 

Corporate investors remain key pillars of life sciences and healthcare

 
Ariana Ognibene, Jonathan Norris

Top life science investment trends for early-stage startups

 

SVB's 2022 healthtech report reveals strong investment opportunity in mental health

 
Christopher Moniz

About the Author

Debi Kutaka is the Senior Fraud Risk Manager on SVB’s Financial Crimes Risk Management team. She is responsible for managing fraud risk and enhancing fraud prevention awareness. In her role, she is focused on  minimizing monetary losses and financial crime for the bank and its  customers through fraud risk analysis, fraud prevention education and client implementation of fraud prevention tools to enhance client security.

With SVB since 2005, her experience includes extensive knowledge of global fraud trends, implementing enhancements of controls, policies and  procedures, assisting business units with efforts to adhere to fraud risk  management best practices and conducting investigations on behalf of our clients.

Debi earned a B.S. in Marketing from San Jose State University and has more than 16 years of banking experience.